— Know what they know.
Not Investment Advice

CRIS NASDAQ

Curis, Inc.
1W: -3.2% 1M: -41.8% 3M: -86.5% YTD: -95.9% 1Y: -97.6% 3Y: -99.5% 5Y: -100.0%
$0.80
-0.03 (-3.29%)
 
Weekly Expected Move ±6.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 25 · $1.6M mcap · 2M float · 14.67% daily turnover · Short 52% of daily vol

Supply Chain Overview

9 relationships
9
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-02-02
Earliest Filing
2025-11-06
Latest Filing
partner: 5 investor: 3 customer: 1

Counterparties (Filed by CRIS)

9 relationships

Companies named in CRIS's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Genentech, Inc. — customer Counterparty to the License Agreement for Erivedge royalties 2025-11-06 View
TPC Investments I LP — investor Limited partnership purchaser of royalty rights 2025-11-06 View
TPC Investments II LP — investor Limited partnership purchaser of royalty rights 2025-11-06 View
Oberland Capital Management, LLC — partner Manager of the Purchaser limited partnerships 2025-11-06 View
TPC Investments Royalty LLC — investor Acquirer of Curis Royalty LLC and Erivedge Business 2025-11-06 View
Laidlaw & Company (UK) Ltd. — partner Co-placement agent for the registered direct offering and private placement. 2025-07-02 View
JonesTrading Institutional Services LLC — partner Co-placement agent for the registered direct offering and private placement. 2025-07-02 View
Cantor Fitzgerald & Co. — partner Agent for the terminated at-the-market sales agreement. 2025-07-02 View
99 Hayden LLC — partner Landlord entering into a lease amendment for additional office space. 2022-02-02 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-07-30 Delisting Notice View
2026-07-02 Bylaws Amendment; Exhibits View
2026-07-01 Bylaws Amendment View
2026-07-01 Bylaws Amendment View
2026-06-25 Shareholder Vote View
2026-05-22 Bylaws Amendment; Shareholder Vote; Exhibits View
2026-05-12 Earnings Release; Exhibits View
2026-05-01 Delisting Notice View
2026-03-17 Material Modification to Rights of Security Holders; Departure/Election of Directors; Appointment of View
2026-02-09 Notice of Delisting or Transfer View
2026-01-08 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art Agreement View
2025-11-13 Financial Statements and Exhibits View
2025-11-06 Termination of Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Re Acquisition View
2025-10-24 Notice of Delisting or Transfer View
2025-08-22 Notice of Delisting or Transfer View
2025-08-08 Other Events; Financial Statements and Exhibits View
2025-08-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-02 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis Agreement View
2025-05-22 Material Modification to Rights of Security Holders; Departure/Election of Directors; Appointment of View
2025-05-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms